EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Tumor Microenvironment in Melanoma—Characteristic and Clinical Implications

Hubert Sikorski iD, Michał Aleksander Żmijewski, Anna Piotrowska iD

International Journal of Molecular Sciences · 15.07.2025 · 26 (14) · 6778

DOI: 10.3390/ijms26146778 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 15.07.2025. Verfasst von Hubert Sikorski und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Histology, Faculty of Medicine, Medical University of Gdańsk, Dębinki 1 Str., 80-211 Gdańsk, Poland. Hauptthemen laut MEDLINE: Tumor Microenvironment, Melanoma, Skin Neoplasms. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 133 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: „Young Creator of Science” Program in Medical University of Gdańsk.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cutaneous melanoma is an aggressive cancer with an increasing incidence worldwide, highlighting the need for research into its pathogenesis. The tumor microenvironment (TME) plays a critical role in melanoma progression and consists of cellular components and an extracellular matrix (ECM) rich in cytokines and signaling molecules. The most abundant stromal cells within the TME are cancer-associated fibroblasts (CAFs), which remodel the ECM and modulate immune responses. Among immune cells, tumor-associated macrophages (TAMs) predominate, and their polarization toward the M2 phenotype supports tumor progression. Tumor-infiltrating lymphocytes (TILs) have diverse functions, including cytotoxic T-cells, helper T-cells that modulate immune response, B-cells forming tertiary lymphoid structures (TLS), and regulatory T-cells with immunosuppressive properties. Dendritic cells (DCs) also play a complex role in the TME. A notable subpopulation are mature regulatory dendritic cells (mregDCs), which contribute to immune evasion. All of these TME components may drive tumorigenesis. Advancements in melanoma treatment—including immunotherapy and targeted therapies—have significantly improved outcomes in advanced-stage disease. In parallel, emerging approaches targeting the tumor microenvironment and gut microbiome, as well as personalized strategies such as neoantigen vaccines and cell-based therapies, are under active investigation and may further enhance therapeutic efficacy in the near future.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor MicroenvironmentMelanomaSkin NeoplasmsHumansDendritic CellsLymphocytes, Tumor-InfiltratingAnimalsImmunotherapy

Stichwörter der Autor:innen

cancer/melanoma-associated fibroblasts (CAFs)dendritic cellsimmune checkpoint inhibitors (ICI)macrophagesmelanomametastasestumor microenvironmenttumor-infiltrating lymphocytes (TILs)

Autor:innen und Institutionen

  • Department of Histology, Faculty of Medicine, Medical University of Gdańsk, Dębinki 1 Str., 80-211 Gdańsk, Poland.

ORCID-Profile: Hubert Sikorski, Anna Piotrowska

Förderung

  • „Young Creator of Science” Program in Medical University of Gdańsk

Zitieren

APA

Sikorski, H., Żmijewski, M. A., & Piotrowska, A. (2025). Tumor Microenvironment in Melanoma—Characteristic and Clinical Implications. International Journal of Molecular Sciences, 26(14), 6778. https://doi.org/10.3390/ijms26146778

Vancouver

Sikorski H, Żmijewski MA, Piotrowska A. Tumor Microenvironment in Melanoma—Characteristic and Clinical Implications. International Journal of Molecular Sciences. 2025;26(14):6778. doi:10.3390/ijms26146778

BibTeX
@article{Sikorski2025,
  author = {Sikorski, Hubert and Żmijewski, Michał Aleksander and Piotrowska, Anna},
  title = {Tumor Microenvironment in Melanoma—Characteristic and Clinical Implications},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {14},
  pages = {6778},
  doi = {10.3390/ijms26146778}
}
Kostenlos starten →